230 Million
people live with peripheral arterial disease worldwide.
A chronic total occlusion (CTO) is the most severe stage — a complete arterial blockage that presents a serious risk of amputation due to lack of blood flow.
Peripheral Arterial Disease
194,000
amputations p.a. in the US and UK
Diabetes is also a major cause of peripheral arterial disease.
A Chronic Total Occlusion (CTO) is the most severe stage of the disease and presents a serious risk of amputation due to the complete lack of blood flow.
22-30
Million
with most advanced
stage (CTO)
60%
Average
Re-entry
Success Rate
Peripheral CTO Re-entry
Re-entering the true lumen past a chronic totalocclusion is one of the hardest steps inperipheral intervention.
The ePATH System is intended to help facilitateplacement of a guidewire beyond a stenoticlesion within the peripheral vasculature.
Vascular Access Creation
For the last 50 years, open surgery has been the current gold standard for preparing patients for dialysis. This involves suturing together an artery and vein in the forearm to create a vascular access site (Arteriovenous Fistula or AVF) for the dialysis machine to connect to.
640,000
surgical AVF creations per year
- [2,3]
Surgical AVF Outcomes
An AVF is a patient's lifeline and is crucial to receiving dialysis treatment. High failure rates of surgical AVFs result in multiple repeat salvage procedures.
25%
Surgical
Failure
50%
1 year
patient
3.43
Salvage Procedures
Per patient year
3-6
Months
Time to heal and mature
Cost of Failure
$5,000 to $15,000
per salvage procedure
$4.6
Billion
US yearly spend on failing
dialysis access sites
The ePATH endoAVF system aims to reduce the burden on patients and healthcare systems through a more reliable alternative to surgical AVF creation.
The ePATH Re-Entry catheter kit will provide clinicians with a safer, more precise, and more reliable approach to CTO True Lumen Re-entry procedures.
110,000
Peripheral CTO procedures globally p.a. (2020)
- [20]
Unit 12, baltimore house, Juniper Dr, London SW18 1TS, United Kingdom
Not available for sale in the United States © 2023 Stent Tek Ltd
Pathfinder Medical is the trading name of Stent Tek Ltd. Company No. 09289469
